News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,704 Results
Type
Article (87072)
Company Profile (704)
Press Release (767913)
Multimedia
Podcasts (156)
Webinars (21)
Section
Business (232913)
Career Advice (4135)
Deals (39772)
Drug Delivery (131)
Drug Development (91152)
Employer Resources (200)
FDA (18219)
Job Trends (17377)
News (397040)
Policy (39862)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56978)
ALS (125)
Alzheimer's disease (1621)
Antibody-drug conjugate (ADC) (195)
Approvals (18194)
Artificial intelligence (421)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (416)
Cancer (3304)
Cardiovascular disease (264)
Career advice (3544)
Career pathing (34)
CAR-T (218)
CDC (43)
Cell therapy (604)
Cervical cancer (26)
Clinical research (74617)
Collaboration (1188)
Company closure (4)
Compensation (798)
Complete response letters (42)
COVID-19 (2921)
CRISPR (71)
C-suite (419)
Cystic fibrosis (126)
Data (3377)
Decentralized trials (2)
Denatured (56)
Depression (85)
Diabetes (391)
Diagnostics (7015)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (196)
Drug pricing (163)
Drug shortages (36)
Duchenne muscular dystrophy (171)
Earnings (98523)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (131761)
Executive appointments (933)
FDA (20289)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1063)
Gene editing (154)
Generative AI (42)
Gene therapy (477)
GLP-1 (969)
Government (5311)
Grass and pollen (7)
Guidances (323)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (16)
Indications (43)
Infectious disease (3129)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (81)
Intellectual property (142)
Interviews (813)
IPO (17911)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (64)
Layoffs (612)
Leadership (27)
Legal (10141)
Liver cancer (87)
Longevity (12)
Lung cancer (460)
Lymphoma (234)
Machine learning (16)
Management (65)
Manufacturing (502)
MASH (111)
Medical device (14780)
Medtech (14792)
Mergers & acquisitions (22638)
Metabolic disorders (1009)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2443)
NextGen: Class of 2025 (7687)
Non-profit (5092)
Now hiring (52)
Obesity (508)
Opinion (298)
Ovarian cancer (108)
Pain (137)
Pancreatic cancer (137)
Parkinson's disease (209)
Partnered (26)
Patents (354)
Patient recruitment (210)
Peanut (55)
People (65872)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23012)
Phase II (32389)
Phase III (24403)
Pipeline (2253)
Policy (265)
Postmarket research (3554)
Preclinical (10399)
Press Release (72)
Prostate cancer (161)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (558)
Real estate (7404)
Recruiting (76)
Regulatory (27431)
Reports (64)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (112)
Series A (176)
Series B (128)
Service/supplier (30)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4310)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (77)
The Weekly (98)
Vaccines (962)
Venture capital (62)
Weight loss (349)
Women's health (53)
Worklife (20)
Date
Today (69)
Last 7 days (675)
Last 30 days (2597)
Last 365 days (33881)
2025 (21243)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (287)
Arkansas (14)
Asia (50651)
Australia (8897)
California (8390)
Canada (2560)
China (767)
Colorado (358)
Connecticut (375)
Delaware (226)
Europe (116301)
Florida (1258)
Georgia (285)
Hawaii (3)
Idaho (67)
Illinois (767)
India (36)
Indiana (408)
Iowa (19)
Japan (251)
Kansas (119)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1168)
Massachusetts (6379)
Michigan (286)
Minnesota (519)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (92)
New Hampshire (75)
New Jersey (2327)
New Mexico (31)
New York (2312)
North Carolina (1300)
North Dakota (10)
Northern California (3685)
Ohio (268)
Oklahoma (17)
Oregon (48)
Pennsylvania (1790)
Puerto Rico (18)
Rhode Island (42)
South America (1654)
South Carolina (39)
South Dakota (1)
Southern California (3149)
Tennessee (136)
Texas (1307)
United States (31431)
Utah (246)
Virginia (228)
Washington D.C. (80)
Washington State (726)
West Virginia (4)
Wisconsin (89)
There are 855,704 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genprex Receives Notice of Allowance for Multiple Patents for Reqorsa® Gene Therapy with PD-L1 and PD-1 Antibodies to Treat Cancers
August 18, 2025
·
6 min read
Press Releases
Atropos Health Enters into Strategic Collaboration to Reduce Time to Rare Disease Diagnosis with Artificial Intelligence (AI) Algorithm
August 18, 2025
·
5 min read
Press Releases
Savara to Present New Data from the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients with Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society Congress 2025
August 18, 2025
·
4 min read
Press Releases
Qihan Biotech Announces FDA Clearance of IND for QT-019B, a Universal Dual-Target CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
August 18, 2025
·
4 min read
Press Releases
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
August 18, 2025
·
7 min read
Press Releases
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
August 18, 2025
·
3 min read
FDA
Leaked MAHA Strategy Emphasizes Vaccine Overhaul, Streamlined Access to Novel Therapies
A draft copy of the Make America Healthy Again Commission’s latest report, obtained by
Politico
, focuses on vaccine-related injuries and expediting access to investigational medicines for children—even though the FDA has recently rejected several of them.
August 18, 2025
·
3 min read
·
Heather McKenzie
Press Releases
Maxwell Biosciences Marks Scientist Appreciation Day With Renewed Call to Recognize Scientists
Company holiday celebrates scientific impact and invites underrecognized researchers to connect
August 18, 2025
·
2 min read
Neuroscience
Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech
Waltham, Massachusetts–based Skyhawk Therapeutics has been collecting collaborations with larger companies in spades since launching in 2018.
August 18, 2025
·
1 min read
·
Dan Samorodnitsky
GLP-1
Novo Teams Up With GoodRx for Lower-Price GLP-1s, Giving DTC Another Shot
Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip insurance. This is not the first time Novo has partnered with a pharmacy to offer the blockbuster drugs.
August 18, 2025
·
1 min read
·
Annalee Armstrong
1 of 85,571
Next
